MBX Biosciences (MBX): Wutah pendapatan kuartal marang kuartal

mbxbio.com (MBX) - logo korporat

Strong institutional confidence confirms the authority of MBX Biosciences Inc (MBX), and the quarterly revenue dynamics on GURU.Markets clearly demonstrate this status, where the value 0.00 represents the current metric. MBX Biosciences Inc (MBX) develops endocrine peptides at the R&D stage, anticipating explosive growth following FDA approval. A team of elite scientists is sustained by generous funding and the uniqueness of their scientific niche.

MBX Wutah dodolan triwulanan MBX Bio (14.09.2024 - 20.11.2026)

MBX Bio - rincian analitis lan metrik utama (MBX)

- rega saham lan target rega konsensus:
- indikator dhuwit lan arus kas:
Pambiji fundamental:MBX Biosciences Inc - MBX
Produk sing diprodhuksi MBX Biosciences, Inc.

Selecting stocks with a high margin of safety begins with an analysis of revenue dynamics. This indicator measures the percentage change in quarterly revenue, identifying the impact of macroeconomics on the business's operational efficiency. For MBX Biosciences Inc (MBX), with its patent-protected peptide platforms, this metric confirms the commercial resilience of its unique developments. The current quarterly revenue growth rate of 0.00 reflects the company's actual expansion speed.

Perusahaan pesaing

ASND - Wutah pendapatan kuartal marang kuartal|MDGL: Wutah pendapatan kuartal marang kuartal|CORT: Wutah pendapatan triwulanan|RYTM - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Akero Corp|Metsera Therapeutics (MTSR) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal moonlaketx.com (MLTX)|Wutah dodolan triwulanan Crinetics Pharmaceuticals CRNX|Wutah pendapatan kuartal marang kuartal NewAmsterdam Pharma N.V. NAMS|Tingkat wutah dodolan sajrone kuartal Soleno Therapeutics Inc (SLNO)|FOLD - Wutah pendapatan kuartal marang kuartal|ETNB: Wutah pendapatan kuartal marang kuartal|AGIO: Wutah pendapatan triwulanan|Structure Therapeutics Inc. - Tambahing pendapatan triwulanan|MDXG (MiMedx Corp) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Rezolute Inc RZLT|Wutah pendapatan triwulanan LXRX|Wutah dodolan triwulanan Altimmune, Inc. ALT|Wutah pendapatan triwulanan AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Tingkat wutah pendapatan sajrone kuartal|BIOA: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan BMEA (Biomea Fusion)|QNCX (quincetx.com) - Wutah dodolan triwulanan|Fractyl - Tambahing pendapatan triwulanan|VTVT (vTv Therapeutics Inc) - Wutah pendapatan triwulanan|Agape ATP - Dinamika pendapatan kuartal marang kuartal|Wutah dodolan triwulanan PLUR (Pluri Inc)|Tingkat wutah dodolan sajrone kuartal Synlogic Inc.|Wutah pendapatan kuartal marang kuartal Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Tingkat wutah pendapatan sajrone kuartal|Spruce Biosciences Inc. - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Wutah pendapatan kuartal marang kuartal|Lumos Pharma - Tambahing pendapatan triwulanan|ONVO (Organovo Corp) - Wutah pendapatan triwulanan|Radius Pharmaceuticals (RDUS) - Tingkat wutah dodolan sajrone kuartal